Wissenschaftliche Arbeiten

Prof. Dr. Enis Özyar

230 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil

  1. Radiotherapy in congenital vulvar lymphangioma circumscriptum

    International Journal of Gynecological Cancer, 2007

    DOI 10.1111/j.1525-1438.2007.01040.x PMID 17692089 8 Zitationen (Europe PMC) Quelle: OpenAlex

  2. Incidence of hypothyroidism after radiotherapy for nasopharyngeal carcinoma

    Medical Oncology, 2007

    DOI 10.1007/bf02685908 PMID 17673817 19 Zitationen (Europe PMC) Quelle: OpenAlex

  3. Radiotherapy in the adjuvant setting of cervical carcinoma: treatment, results, and prognostic factors

    International Journal of Gynecological Cancer, 2007

    DOI 10.1111/j.1525-1438.2007.00887.x PMID 17359296 1 Zitation (Europe PMC) Quelle: OpenAlex

  4. Use of Plasma Epstein-Barr virus DNA Monitoring as a Tumor Marker in follow-up of Patients with Nasopharyngeal Carcinoma: Preliminary Results and Report of two Cases

    The International Journal of Biological Markers, 2007

    DOI 10.1177/172460080702200305 PMID 17922462 4 Zitationen (Europe PMC) Quelle: OpenAlex

  5. 5504 ORAL Quantification of plasma Epstein-Barr virus DNA in patients with nasopharyngeal carcinoma: results of a prospective study

    European Journal of Cancer Supplements, 2007

    DOI 10.1016/s1359-6349(07)71221-1 Quelle: OpenAlex

  6. Bowen hastalığı tedavisinde mold brakiterapisi: Bir olgu nedeni ile literatür derlemesi

    DergiPark (Istanbul University), 2006

    Quelle: OpenAlex

  7. Radiotherapy in the treatment of mucosal melanoma of the upper aerodigestive tract: Analysis of 74 cases. A Rare Cancer Network study

    International Journal of Radiation Oncology*Biology*Physics, 2006

    DOI 10.1016/j.ijrobp.2006.01.016 PMID 16647223 97 Zitationen (Europe PMC) Quelle: OpenAlex

  8. Treatment results of 165 pediatric patients with non-metastatic nasopharyngeal carcinoma: A Rare Cancer Network study

    Radiotherapy and Oncology, 2006

    DOI 10.1016/j.radonc.2006.08.019 PMID 16965827 56 Zitationen (Europe PMC) Quelle: OpenAlex

  9. Radiotherapy in the management of Kaposi's sarcoma: comparison of 8 Gy versus 6 Gy.

    PubMed Central, 2006

    PMID 16895284 15 Zitationen (Europe PMC) Quelle: OpenAlex

  10. Bimodal age distribution in Hodgkin’s disease and nasopharyngeal carcinoma

    Medical Hypotheses, 2006

    DOI 10.1016/j.mehy.2006.11.014 PMID 17196754 12 Zitationen (Europe PMC) Quelle: OpenAlex

  11. Evaluation of radiotherapy response of cervical carcinoma with gray scale and color Doppler ultrasonography: resistive index correlation with magnetic resonance findings.

    PubMed, 2006

    PMID 16972223 7 Zitationen (Europe PMC) Quelle: OpenAlex

  12. Nazofarenks kanserli hastalarda geç yan etki olarak ortaya çıkan trismus gelişimine etkili faktörler

    DergiPark (Istanbul University), 2006

    Quelle: OpenAlex

  13. In regards to: Adjuvant radiotherapy after transoral laser microsurgery for advanced squamous cell carcinoma of the head and neck by Pradier et al. (Int J Radiat Oncol Biol Phys 2005;63:1368–1377)

    International Journal of Radiation Oncology*Biology*Physics, 2006

    DOI 10.1016/j.ijrobp.2006.02.032 PMID 16751078 Quelle: OpenAlex

  14. İntrakraniyal Metastaz ve KİBAS

    Türkiye klinikleri cerrahi tıp bilimleri, 2006

    Quelle: OpenAlex

  15. Relapse Pattern of GOG 122 Trial Should Be More Informative

    Journal of Clinical Oncology, 2006

    DOI 10.1200/jco.2006.06.8833 PMID 16877741 Quelle: OpenAlex

  16. 2353

    International Journal of Radiation Oncology*Biology*Physics, 2006

    DOI 10.1016/j.ijrobp.2006.07.762 Quelle: OpenAlex

  17. 2384

    International Journal of Radiation Oncology*Biology*Physics, 2006

    DOI 10.1016/j.ijrobp.2006.07.793 Quelle: OpenAlex

  18. Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&N-35 modules

    International Journal of Radiation Oncology*Biology*Physics, 2005

    DOI 10.1016/j.ijrobp.2005.05.057 PMID 16169671 45 Zitationen (Europe PMC) Quelle: OpenAlex

  19. Treatment results of 84 patients with nasopharyngeal carcinoma in childhood

    Pediatric Blood & Cancer, 2005

    DOI 10.1002/pbc.20433 PMID 16200569 31 Zitationen (Europe PMC) Quelle: OpenAlex

  20. Trismus as a presenting symptom in nasopharyngeal carcinoma

    Radiotherapy and Oncology, 2005

    DOI 10.1016/j.radonc.2005.07.006 PMID 16154654 11 Zitationen (Europe PMC) Quelle: OpenAlex

  21. Post-operative radiotherapy in advanced laryngeal cancer: effect on local and regional recurrence, distant metastases and second primaries

    The Journal of Laryngology & Otology, 2005

    DOI 10.1258/002221505774481183 PMID 16259655 16 Zitationen (Europe PMC) Quelle: OpenAlex

  22. Treatment Results of 165 Pediatric Patients with Non-Metastatic Nasopharyngeal Carcinoma: A Rare Cancer Network Study

    International Journal of Radiation Oncology*Biology*Physics, 2005

    DOI 10.1016/j.ijrobp.2005.07.047 Quelle: OpenAlex

  23. In regards to Sze et al.: Primary tumor volume of nasopharyngeal carcinoma: Prognostic significance for local control (Int J Radiat Oncol Biol Phys 2004;59:21–27)

    International Journal of Radiation Oncology*Biology*Physics, 2005

    DOI 10.1016/j.ijrobp.2004.10.006 PMID 15667986 2 Zitationen (Europe PMC) Quelle: OpenAlex

  24. Undifferentiated nasopharyngeal carcinoma with isolated central nervous system metastasis

    Archive of oncology, 2004

    DOI 10.2298/aoo0402121o Quelle: OpenAlex

  25. Prospective study of combined modality treatment or radiotherapy alone in the management of early-stage adult Hodgkin's disease

    International Journal of Radiation Oncology*Biology*Physics, 2004

    DOI 10.1016/j.ijrobp.2004.04.002 PMID 15465201 2 Zitationen (Europe PMC) Quelle: OpenAlex

  26. Prognostic Role of Ebstein-Barr Virus Latent Membrane Protein-1 and Interleukin-10 Expression in Patients with Nasopharyngeal Carcinoma

    Cancer Investigation, 2004

    DOI 10.1081/cnv-200026386 PMID 15565804 20 Zitationen (Europe PMC) Quelle: OpenAlex

  27. Salvage Ifosfamide–Doxorubicin Chemotherapy in Patients with Recurrent Nasopharyngeal Carcinoma Pretreated with Cisplatin-Based Chemotherapy

    Medical Oncology, 2004

    DOI 10.1385/mo:21:3:211 PMID 15456947 14 Zitationen (Europe PMC) Quelle: OpenAlex

  28. Treatment results of 59 young patients with nasopharyngeal carcinoma

    International Journal of Pediatric Otorhinolaryngology, 2004

    DOI 10.1016/j.ijporl.2004.09.001 PMID 15656953 14 Zitationen (Europe PMC) Quelle: OpenAlex

  29. Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: Results of single-center study of 45 patients

    Head & Neck, 2004

    DOI 10.1002/hed.20107 PMID 15515158 27 Zitationen (Europe PMC) Quelle: OpenAlex

  30. Unusual hypersensitivity to radiation therapy in a patient with dyskeratosis congenita syndrome

    Oral Oncology, 2004

    DOI 10.1016/j.oraloncology.2004.01.001 PMID 15172647 11 Zitationen (Europe PMC) Quelle: OpenAlex

  31. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival

    Radiotherapy and Oncology, 2004

    DOI 10.1016/j.radonc.2004.02.012 PMID 15236877 12 Zitationen (Europe PMC) Quelle: OpenAlex

  32. Assessment of quality life of nasopharyngeal carcinoma patients with EORTC QLQ C30 and H&N 30: Turkish oncology group, head and neck working party study

    International Journal of Radiation Oncology*Biology*Physics, 2004

    DOI 10.1016/j.ijrobp.2004.07.558 Quelle: OpenAlex

  33. In regard to Laskar et al.: Nasopharyngeal carcinoma in children: Ten years' experience at the Tata Memorial Hospital, Mumbai (Int J Radiat Oncol Biol Phys 2004;58:189–195)

    International Journal of Radiation Oncology*Biology*Physics, 2004

    DOI 10.1016/j.ijrobp.2004.04.055 PMID 15380607 Frei zugänglicher VolltextQuelle: OpenAlex

  34. With regard to “Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer” by Oh et al. (AnnOnc 2003; 14: 564–569)

    Annals of Oncology, 2004

    DOI 10.1093/annonc/mdh151 PMID 15033682 Quelle: OpenAlex

  35. Ifosfamide-doxorubicin combination in patients with locally recurrent or metastatic nasopharyngeal carcinoma pretreated with cisplatin based chemotherapy: Retrospective analysis of 21 patients

    Journal of Clinical Oncology, 2004

    DOI 10.1200/jco.2004.22.14_suppl.5603 Quelle: OpenAlex

  36. Frequency of skeletal metastases in nasopharyngeal carcinoma after initiation of therapy: should bone scans be used for follow-up?

    Nuclear Medicine Communications, 2003

    DOI 10.1097/00006231-200312000-00005 PMID 14627849 10 Zitationen (Europe PMC) Quelle: OpenAlex

  37. Waldeyer’s Ring Lymphomas

    American Journal of Clinical Oncology, 2003

    DOI 10.1097/01.coc.0000027588.56104.15 PMID 14528067 16 Zitationen (Europe PMC) Quelle: OpenAlex

  38. Amifostine has No Protective Effect During Concomittant Chemoradiotherapy Given For Cervical Carcinoma

    International Journal of Gynecological Cancer, 2003

    DOI 10.1136/ijgc-00009577-200303001-00082 Quelle: OpenAlex

  39. Adjuvant high-dose-rate brachytherapy after external beam radiotherapy in nasopharyngeal carcinoma

    International Journal of Radiation Oncology*Biology*Physics, 2002

    DOI 10.1016/s0360-3016(01)01818-1 PMID 11777627 22 Zitationen (Europe PMC) Quelle: OpenAlex

  40. Mold brachytherapy can be an optional technique for total scalp irradiation

    International Journal of Radiation Oncology*Biology*Physics, 2002

    DOI 10.1016/s0360-3016(02)03017-1 PMID 12419458 15 Zitationen (Europe PMC) Quelle: OpenAlex

  41. Is There a Survival Benefit to Adjuvant Radiotherapy in High-Risk Surgical Stage I Endometrial Cancer?

    Gynecologic Oncology, 2002

    DOI 10.1006/gyno.2002.6630 PMID 12217745 19 Zitationen (Europe PMC) Quelle: OpenAlex

  42. In regard to Cheng et al., examining prognostic factors of failure in nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy: impact on future clinical trials. IJROBP 2001;50:717–726

    International Journal of Radiation Oncology*Biology*Physics, 2002

    DOI 10.1016/s0360-3016(01)02765-1 PMID 11958916 Quelle: OpenAlex

  43. Malignancy in Behçet’s Disease: A Report of 13 Cases and a Review of the Literature

    Clinical Rheumatology, 2001

    DOI 10.1007/s100670170036 PMID 11529628 27 Zitationen (Europe PMC) Quelle: OpenAlex

  44. RADIOTHERAPY IN THE MANAGEMENT OF KASABACH-MERRITT SYNDROME: A Case Report

    Pediatric Hematology and Oncology, 2001

    DOI 10.1080/088800101750476069 PMID 11594711 5 Zitationen (Europe PMC) Quelle: OpenAlex

  45. Prognostic role of ebstein barr virus latent membrane protein-1 and interleukin-10 expression in patients with nasopharyngeal carcinoma

    European Journal of Cancer, 2001

    DOI 10.1016/s0959-8049(01)81331-9 Quelle: OpenAlex

  46. Prognostic role of Ebstein Barr virus latent membrane Protein-1 and Interleukin-10 expression in patients with nasopharyngeal carcinoma

    International Journal of Radiation Oncology*Biology*Physics, 2001

    DOI 10.1016/s0360-3016(01)02251-9 Quelle: OpenAlex

  47. Two cases of Stevens–Johnson syndrome: toxic epidermal necrolysis possibly induced by amifostine during radiotherapy

    British Journal of Dermatology, 2000

    DOI 10.1046/j.1365-2133.2000.03847.x PMID 11069524 20 Zitationen (Europe PMC) Quelle: OpenAlex

  48. Prognostic Value of p53, Proliferating cell Nuclear Antigen, and Ki‐67 Expression in Undifferentiated Nasopharyngeal Carcinomas

    Otolaryngology, 2000

    DOI 10.1016/s0194-5998(00)70016-7 PMID 10828801 11 Zitationen (Europe PMC) Quelle: OpenAlex

  49. Sucralfate in the Prevention of Radiation-Induced Oral Mucositis

    Journal of Clinical Gastroenterology, 1999

    DOI 10.1097/00004836-199901000-00009 PMID 9916664 51 Zitationen (Europe PMC) Quelle: OpenAlex

  50. Comparison of AJCC 1988 and 1997 classifications for nasopharyngeal carcinoma

    International Journal of Radiation Oncology*Biology*Physics, 1999

    DOI 10.1016/s0360-3016(99)00098-x PMID 10421542 41 Zitationen (Europe PMC) Quelle: OpenAlex